Latest Headlines

  1. Renew Biotechnologies Unifies Wasatch BioLabs And Resonant Under One Brand To Advance Sequencing-Based Diagnostics 7/9/2026

    Renew Biotechnologies today announced the consolidation of Wasatch BioLabs and Resonant under the Renew Biotechnologies brand, creating a unified platform to advance sequencing-based diagnostics, translational research, and clinical testing.

  2. Roche Receives CE Mark For Blood Test To Identify Tuberculosis Infection 7/9/2026

    Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that its Elecsys IGRA TB test has received the CE Mark, introducing a new blood testing solution for identifying tuberculosis infection (TBI, also known as latent TB) in routine laboratory settings.

  3. NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic For Prostate Cancer 7/9/2026

    NeoGenomics, Inc., a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) companion diagnostic test approved by the U.S. Food and Drug Administration (FDA) for patients with prostate adenocarcinoma.

  4. Tethis Expands Global Access To SmartBioSurface® Through New Channel Partners In Brazil, India, China And South Africa 7/8/2026
  5. Quest Diagnostics Now The Largest Clinical Reference Lab To Extend Oncology Test Access Through OncoEMR MPI 7/8/2026

    Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced it is integrating its Haystack MRD® ctDNA test and Comprehensive Genomic Profiling services for solid tumor cancers within OncoEMR®, an electronic health record (EHR) from Flatiron Health, via a pilot program with American Oncology Network (AON) and other community oncology providers.

  6. Ethos Laboratories Announces Exclusive U.S. Launch Of CNSDose™, Following Successful MolDX® Technical Assessment 7/7/2026

    Ethos Laboratories today announced the national launch of CNSDose™, a pharmacogenomic testing platform that will be offered throughout the United States under an exclusive licensing agreement with Incite Genomics.

  7. Kythera Labs Expands Partnership With Databricks Launching The Clinical Semantic Bridge MCP On Databricks Marketplace 7/7/2026

    Kythera Labs, a data technology leader that enables higher fidelity in healthcare data for Health Provider and Life Sciences organizations and recipient of the 2026 Databricks ISV Innovation Built-On Partner of the Year Award announces the launch of the Clinical Semantic Bridge MCP on the Databricks Marketplace.

  8. Stanford Blood Center Expands Transplantation Support With Launch Of Organ And Tissue Donor Infectious Disease Testing 7/7/2026

    Stanford Blood Center (SBC) today announced the successful launch of its testing services, including infectious disease and immunohematology, for Organ Procurement Organizations and Tissue Banks, expanding its specialized laboratory services to support organ and tissue donations throughout Northern California and beyond.

  9. New Atellica HEMA 580 Analyzer From Siemens Healthineers Helps Labs Deliver Fast, Consistent Results To Improve Clinical Decision-Making 7/7/2026

    Siemens Healthineers now offers U.S. laboratories a comprehensive hematology solution that brings together automation, middleware, and remote digital slide review to help deliver time-sensitive patient results with greater consistency.

  10. Beckman Coulter Diagnostics Expands Alzheimer's Portfolio With CE-Marked p-Tau217 Blood Test And New High-Specificity Research Assay 7/7/2026

    Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE Mark under IVDR for its Access p-Tau217 assay, a blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline.